These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 34513354)

  • 1. Hypercalcemia and Renal Mass: A Diagnostically Challenging Case.
    Karki S; Galiveeti S; Leung V
    Cureus; 2021 Jul; 13(7):e16718. PubMed ID: 34513354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conflicting actions of parathyroid hormone-related protein and serum calcium as regulators of 25-hydroxyvitamin D(3)-1 alpha-hydroxylase expression in a nude rat model of humoral hypercalcemia of malignancy.
    Michigami T; Yamato H; Suzuki H; Nagai-Itagaki Y; Sato K; Ozono K
    J Endocrinol; 2001 Nov; 171(2):249-57. PubMed ID: 11691644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypercalcemia in non-Hodgkin's lymphoma due to cosecretion of PTHrP and 1,25-dihydroxyvitamin D.
    Gonciulea AR; Wang Y; Bikle DD; Sellmeyer DE
    Osteoporos Int; 2021 Dec; 32(12):2587-2592. PubMed ID: 34230999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine Carcinoma as a Cause of Humoral Hypercalcemia of Malignancy: A Case of a Patient With Elevated Parathyroid Hormone-Related Protein.
    Christensen BR; Rendo MJ; Beeler BW; Huddleston BJ; Fenderson JL
    Cureus; 2022 Mar; 14(3):e23398. PubMed ID: 35481321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypercalcemia of Malignancy and Colorectal Cancer.
    Galindo RJ; Romao I; Valsamis A; Weinerman S; Harris YT
    World J Oncol; 2016 Feb; 7(1):5-12. PubMed ID: 26998187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant Hypercalcemia Due to the Ectopic Production of Calcitriol by an Abdominal Liposarcoma.
    Figueiredo A; Pereira T; Cabrera R; Simões-Pereira J; Leite V
    Cureus; 2023 Jan; 15(1):e33446. PubMed ID: 36751194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypercalcemia of malignancy in metastatic esophageal squamous cell carcinoma with simultaneous PTHrP and calcitriol overproduction: A case report with literature review.
    Song R; Bijay Y; Rizk SH; Cao S
    Ann Med Surg (Lond); 2021 Aug; 68():102667. PubMed ID: 34401137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Continuous PTH and PTHrP infusion causes suppression of bone formation and discordant effects on 1,25(OH)2 vitamin D.
    Horwitz MJ; Tedesco MB; Sereika SM; Syed MA; Garcia-Ocaña A; Bisello A; Hollis BW; Rosen CJ; Wysolmerski JJ; Dann P; Gundberg C; Stewart AF
    J Bone Miner Res; 2005 Oct; 20(10):1792-803. PubMed ID: 16160737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypercalcemia of malignancy: a study of clinical features and relationships among circulating levels of calcium, parathyroid hormone and parathyroid hormone-related peptide.
    Sriussadaporn S; Phoojaroenchanachai M; Ploybutr S; Plengvidhya N; Peerapatdit T; Nitiyanant W; Vannasaeng S; Vichayanrat A
    J Med Assoc Thai; 2007 Apr; 90(4):663-71. PubMed ID: 17487119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parathyroid hormone-related protein (PTHrP) does not regulate 1,25-dihydroxyvitamin D serum levels in hypercalcemia of malignancy.
    Schilling T; Pecherstorfer M; Blind E; Leidig G; Ziegler R; Raue F
    J Clin Endocrinol Metab; 1993 Mar; 76(3):801-3. PubMed ID: 8445039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.
    Sato K; Onuma E; Yocum RC; Ogata E
    Semin Oncol; 2003 Oct; 30(5 Suppl 16):167-73. PubMed ID: 14613038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased renal calcium reabsorption by parathyroid hormone-related protein is a causative factor in the development of humoral hypercalcemia of malignancy refractory to osteoclastic bone resorption inhibitors.
    Onuma E; Azuma Y; Saito H; Tsunenari T; Watanabe T; Hirabayashi M; Sato K; Yamada-Okabe H; Ogata E
    Clin Cancer Res; 2005 Jun; 11(11):4198-203. PubMed ID: 15930357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: Unmasking Hypercalcemia in Patients With Neuroendocrine Neoplasms. Experience From Six Italian Referral Centers.
    Giannetta E; Sesti F; Modica R; Grossrubatscher EM; Guarnotta V; Ragni A; Zanata I; Colao A; Faggiano A
    Front Endocrinol (Lausanne); 2021; 12():665698. PubMed ID: 34093441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypercalcemia Due to Paraneoplastic Production of 1,25- Dihydroxyvitamin D in a Young Female with Dysgerminoma.
    Iqbal I; Khan MAA; Khan Y; Thalambedu N; Munir S
    Cureus; 2019 Nov; 11(11):e6097. PubMed ID: 31886038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
    Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
    J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Missed diagnosis of lymphoma presenting with humoral hypercalcemia of malignancy due to cessation of oncological workup after negative computed tomography scans.
    Altshuler E; Aryan M; King W; Otero R
    BMJ Case Rep; 2021 Dec; 14(12):. PubMed ID: 34969803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitriol induced hypercalcemia - a rare phenomenon in lung cancer: A case report.
    Prakash A; Khalid F; Alalwan A; Bader H; Du D; Meghal T
    World J Clin Oncol; 2023 Nov; 14(11):544-548. PubMed ID: 38059187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitriol Elevation Is Associated with a Higher Risk of Refractory Hypercalcemia of Malignancy in Solid Tumors.
    Chukir T; Liu Y; Hoffman K; Bilezikian JP; Farooki A
    J Clin Endocrinol Metab; 2020 Apr; 105(4):e1115-23. PubMed ID: 31841590
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1,25-dihydroxyvitamin D-mediated hypercalcemia in ovarian dysgerminoma.
    Hibi M; Hara F; Tomishige H; Nishida Y; Kato T; Okumura N; Hashimoto T; Kato R
    Pediatr Hematol Oncol; 2008; 25(1):73-8. PubMed ID: 18231957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypercalcemia of Malignancy: Simultaneous Elevation in Parathyroid Hormone-Related Peptide and 1,25 Dihydroxyvitamin D in Sarcoma.
    Kim DW; Miller A; Li A; Hardy N; Silver KD
    AACE Clin Case Rep; 2021; 7(3):169-173. PubMed ID: 34095480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.